Business Digest for 9/5/13
Pfizer pays $1M to Waltham firm
Repligen Corp. of Waltham (Nasdaq:RGEN) has received a $1 million milestone payment from Pfizer Inc. under the terms of the companies' exclusive worldwide licensing agreement for the development of compounds to treat spinal muscular atrophy (SMA). This first milestone payment was triggered by completion of specific program activities and coincides with the successful completion of all transition obligations by Repligen. Repligen announced the agreement in January, at which time it received an upfront payment of $5 million. Repligen remains eligible to receive up to $64 million in additional success-based milestone payments, as well as royalties on any future sales of compounds developed under the agreement.
Hydroponics opens new Framingham store
New England Hydroponics has opened its new Framingham store at Trolley Square, 855 Worcester Road (Rte. 9). More information is available at neHyrdro.com.
Sudbury Herb Chambers hosts 'Cars and Coffee’
Herb Chambers BMW of Sudbury hosts a Cars & Coffee event for car enthusiasts showcasing antique, classic, exotic, hotrods, motorcycles and motorsports collections from New England and around the world on Saturday, Sept. 7, from 7 to 10 a.m. at the 128 Boston Post Road location.
Bath & Body Works event Sept. 21
Bath & Body Works locations throughout the region will take part in the Blue Ribbon Pumpkin Review on Saturday, Sept. 21, in which shoppers can judge which new pumpkin candles are their favorites. More details are available at bathandbodyworks.com.
ActiveRX in Westborough plans talk
ActiveRx Active Aging Center, 24 Lyman St., Suite 140 in Westborough, will host "Lunch & Learn" Saturday, Sept. 21, from noon to 1 p.m., to educate mature adults on how they can recover 10 or more years of lost strength and function to enable them to live independent and pain-free lives. Complimentary lunch and beverages will be served. Reservations suggested. Call 508-329-1163.
Repligen, Curis to present at Stifel Healthcare
Waltham-based Repligen Corp. President and CEO Walter Herlihy will present an overview of the company at the Stifel Healthcare Conference on Wednesday, Sept. 11, at the Four Seasons Hotel in Boston. The Repligen presentation will be webcast live and can be accessed through the Investors section of company's website, repligen.com. Repligen (Nasdaq:RGEN) is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs.
Curis Inc. (Nasdaq:CRIS), a Lexington-based oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, has announced Ali Fattaey, president and COO, will present a brief overview of the company’s business strategy and answer questions at the Stifel Healthcare Conference on Thursday, Sept. 12. The presentation will be available for 30 days on the Investor Relations section of the Curis website, curis.com.